Search results
Results From The WOW.Com Content Network
The Anti-Kickback Statute [1] (AKS) is an American federal law prohibiting financial payments or incentives for referring patients or generating federal healthcare business. . The law, codified at 42 U.S. Code § 1320a–7b(b), [2] imposes criminal and, particularly in association with the federal False Claims Act, civil liability on those who knowingly and willfully offer, solicit, receive ...
Statutory Anti-Kickback Liability. The federal Anti-Kickback Statute, 42 U.S.C. 1320a-7b(b) (AKS) is a criminal statute which makes it improper for anyone to solicit, receive, offer or pay remuneration (monetary or otherwise) in exchange for referring patients to receive certain services that are paid for by the government. Previously, many ...
A Monsey doctor and his wife pleaded guilty to charges of taking kickbacks and bribes in exchange for $1 million in genetic tests.. U.S. Attorney for the District of New Jersey Philip R. Sellinger ...
Signed into law by President Ronald Reagan on November 7, 1986 The Anti-Kickback Enforcement Act of 1986 ( Pub. L. 99–634 , 100 Stat. 3523 , enacted November 7, 1986 , originally codified at 41 U.S.C. § 51 et seq., recodified at 41 U.S.C. ch. 87 ) modernized and closed the loopholes of previous statutes applying to government contractors .
A judge dismissed Pfizer Inc's challenge to a U.S. anti-kickback law that the drugmaker said prevents it from helping Medicare patients afford two drugs that treat a sometimes fatal heart ...
False Claims Act, Medicaid Rebate Statute 2007 Purdue Pharma [15] $601 million Off-label promotion Oxycontin: False Claims Act 2010 Allergan [16] $600 million Off-label promotion Botox: False Claims Act, FDCA 2010 AstraZeneca [17] $520 million Off-label promotion, kickbacks Seroquel: False Claims Act 2007 Bristol-Myers Squibb [18] $515 million
Alabama state Rep. John Rogers has pleaded not guilty to a charge of attempting to obstruct a federal investigation into an alleged kickback scheme involving state grants. The longtime lawmaker ...
Kopchinski and his attorneys filed the False Claims Act complaint in 2004 and alleged Pfizer systemically violated the federal Anti-Kickback statute, 42 U.S.C. § 1320a-7b(b) and the off-label marketing provision within the Federal Food, Drug, and Cosmetic Act ("FDCA"), 21 U.S.C. §§ 301-97. [37]